The Lancet Oncology

Editor in Chief: David Collingridge, PhD

The Lancet Oncology, published monthly, provides oncology-related specialists something truly rare and valuable—definitive coverage of all aspects of oncology from around the world—in a single, highly readable source.

The aim of The Lancet Oncology is to publish interesting and informative research on any topic connected with oncology. The journal's great reputation and high profile allowed it to extend into the field of primary research from May 2005.

For our advertisers, this high profile journal provides an excellent platform from which to advertise your products and services relevant to the oncology professional. We are confident that The Lancet Oncology is the first place oncology related specialists look when investigating well-respected opinion, news and reviews, or the latest in important clinical trials. 

Global Print Circulation
Circulation updated on February 27, 2023, based on December 2022 BPA Brand Report., eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023,

Rate Card

Find the best value for your advertising dollars

Journal Website

Find out more directly from the source

Journal Metrics

Detailed insights into the reach and penetration of this journal

Have a question or need assistance?